These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2973559)

  • 1. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
    Leenders KL; Frackowiak RS; Quinn N; Marsden CD
    Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
    Gaura V; Bachoud-Lévi AC; Ribeiro MJ; Nguyen JP; Frouin V; Baudic S; Brugières P; Mangin JF; Boissé MF; Palfi S; Cesaro P; Samson Y; Hantraye P; Peschanski M; Remy P
    Brain; 2004 Jan; 127(Pt 1):65-72. PubMed ID: 14607797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
    Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
    Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral blood flow and metabolism in Lafora disease].
    Tsuda H; Katsumi Y; Nakamura M; Ikeda A; Fukuyama H; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1995 Feb; 35(2):175-9. PubMed ID: 7781235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in movement disorders.
    Martin WR
    Can J Neurol Sci; 1985 Feb; 12(1):6-10. PubMed ID: 3156662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography.
    Sawle GV; Brooks DJ; Marsden CD; Frackowiak RS
    Brain; 1991 Feb; 114 ( Pt 1B)():541-56. PubMed ID: 1900728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.
    Leenders KL; Frackowiak RS; Quinn N; Brooks D; Sumner D; Marsden CD
    Mov Disord; 1986; 1(1):51-8. PubMed ID: 2973558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral glucose metabolism and striatal 18F-dopa uptake by PET in cases of chorea with or without dementia.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Fukumura T; Masuda K; Goto I; Kato M
    J Neurol Sci; 1993 Apr; 115(2):153-7. PubMed ID: 8482976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography.
    Leenders KL; Frackowiak RS; Lees AJ
    Brain; 1988 Jun; 111 ( Pt 3)():615-30. PubMed ID: 3133078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroimaging in movement disorders--CT, MRI, and PET study].
    Kobayashi O; Sakuragawa N
    Nihon Rinsho; 1993 Nov; 51(11):2891-6. PubMed ID: 8277567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].
    Tanji H; Nagasawa H; Itoh M; Itoyama Y
    Nihon Rinsho; 1997 Jan; 55(1):89-94. PubMed ID: 9014428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional imaging for disorders of basal ganglia].
    Otsuka M; Taniwaki T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.